{"entity":{"type":"insider","cik":"0001733272","url":"/insider/0001733272","json_url":"/insider/0001733272.json","name":"Yocca Frank","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":15,"first":"2018-11-30","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Yocca Frank","source":"filing","n_filings":15,"first_seen":"2018-11-30","last_seen":"2026-05-22"}],"transactions":[{"id":5856016,"accession":"0001104659-26-065841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-065841","line_url":"/filing/0001104659-26-065841#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6845.0,"shares_display":"6,845","price_per_share":1.085,"price_display":"1.08","price_state":"stated","total_value":7426.825,"total_display":"7,426.82","total_whole":"7,427","shares_owned_after":26175.0,"shares_owned_after_display":"26,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider"},{"id":3023166,"accession":"0001104659-24-129457","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-129457","line_url":"/filing/0001104659-24-129457","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":0.3530593023255814,"price_display":"0.35","price_state":"stated","total_value":151.8155,"total_display":"151.82","total_whole":"152","shares_owned_after":28931.0,"shares_owned_after_display":"28,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-17","scope":"insider","n_lines":2},{"id":2315251,"accession":"0001104659-24-106062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-106062","line_url":"/filing/0001104659-24-106062#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7175.0,"shares_display":"7,175","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":3946.25,"total_display":"3,946.25","total_whole":"3,946","shares_owned_after":28278.0,"shares_owned_after_display":"28,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-03","scope":"insider"},{"id":2035523,"accession":"0001104659-24-100752","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-100752","line_url":"/filing/0001104659-24-100752#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":355.0,"shares_display":"355","price_per_share":0.6893,"price_display":"0.69","price_state":"stated","total_value":244.7015,"total_display":"244.70","total_whole":"245","shares_owned_after":14203.0,"shares_owned_after_display":"14,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2184391,"accession":"0001104659-24-073004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-073004","line_url":"/filing/0001104659-24-073004#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":372.0,"shares_display":"372","price_per_share":1.28,"price_display":"1.28","price_state":"stated","total_value":476.16,"total_display":"476.16","total_whole":"476","shares_owned_after":13474.0,"shares_owned_after_display":"13,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-18","scope":"insider"},{"id":2599618,"accession":"0001104659-24-044857","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-044857","line_url":"/filing/0001104659-24-044857#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1067.0,"shares_display":"1,067","price_per_share":2.635,"price_display":"2.64","price_state":"stated","total_value":2811.545,"total_display":"2,811.54","total_whole":"2,812","shares_owned_after":12763.0,"shares_owned_after_display":"12,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":8472823,"accession":"0001104659-23-033406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-033406","line_url":"/filing/0001104659-23-033406#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":985.0,"shares_display":"985","price_per_share":19.6911,"price_display":"19.69","price_state":"stated","total_value":19395.7335,"total_display":"19,395.73","total_whole":"19,396","shares_owned_after":9496.0,"shares_owned_after_display":"9,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-15","filed_date":"2023-03-16","scope":"insider"},{"id":8696984,"accession":"0001104659-23-006298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-006298","line_url":"/filing/0001104659-23-006298#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":8397.0,"shares_owned_after_display":"8,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-24","scope":"insider"},{"id":4210776,"accession":"0001104659-21-037765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-037765","line_url":"/filing/0001104659-21-037765","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":48.50486,"price_display":"48.50","price_state":"stated","total_value":727572.9,"total_display":"727,572.90","total_whole":"727,573","shares_owned_after":59027.0,"shares_owned_after_display":"59,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider","n_lines":2},{"id":4129542,"accession":"0001104659-21-025271","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-21-025271","line_url":"/filing/0001104659-21-025271","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":57.67687466666667,"price_display":"57.68","price_state":"stated","total_value":865153.12,"total_display":"865,153.12","total_whole":"865,153","shares_owned_after":80292.0,"shares_owned_after_display":"80,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider","n_lines":7},{"id":5247318,"accession":"0001104659-21-008192","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-21-008192","line_url":"/filing/0001104659-21-008192","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":48.38761866666667,"price_display":"48.39","price_state":"stated","total_value":725814.28,"total_display":"725,814.28","total_whole":"725,814","shares_owned_after":92504.0,"shares_owned_after_display":"92,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider","n_lines":4},{"id":8145965,"accession":"0001104659-19-045930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-045930","line_url":"/filing/0001104659-19-045930#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6547.0,"shares_display":"6,547","price_per_share":8.67,"price_display":"8.67","price_state":"stated","total_value":56762.49,"total_display":"56,762.49","total_whole":"56,762","shares_owned_after":8397.0,"shares_owned_after_display":"8,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider"},{"id":6221321,"accession":"0001104659-18-071465","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-071465","line_url":"/filing/0001104659-18-071465#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":5.1973,"price_display":"5.20","price_state":"stated","total_value":2338.785,"total_display":"2,338.78","total_whole":"2,339","shares_owned_after":1850.0,"shares_owned_after_display":"1,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-06","scope":"insider"},{"id":6221317,"accession":"0001104659-18-071465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-071465","line_url":"/filing/0001104659-18-071465#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":5.2299,"price_display":"5.23","price_state":"stated","total_value":2353.455,"total_display":"2,353.46","total_whole":"2,353","shares_owned_after":1400.0,"shares_owned_after_display":"1,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6413645,"accession":"0001104659-18-070875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-070875","line_url":"/filing/0001104659-18-070875#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":5.199,"price_display":"5.20","price_state":"stated","total_value":2339.55,"total_display":"2,339.55","total_whole":"2,340","shares_owned_after":950.0,"shares_owned_after_display":"950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-11-30","scope":"insider"},{"id":6496116,"accession":"0001104659-18-070795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-070795","line_url":"/filing/0001104659-18-070795#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733272","owner_name":"Yocca Frank","owner_display_name":"Yocca Frank","owner_url":"/insider/0001733272","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.0223,"price_display":"5.02","price_state":"stated","total_value":2511.15,"total_display":"2,511.15","total_whole":"2,511","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-11-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720893","name":"BioXcel Therapeutics, Inc.","url":"/issuer/0001720893","role":"Officer (Chief Scientific Officer)","n_filings":15,"first_seen":"2018-11-30","last_seen":"2026-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001733272","retrieved_at":"2026-08-26T16:50:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}